NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹773 Cr | ₹674 Cr | ₹493 Cr | ₹322 Cr | ₹218 Cr |
What is the latest Net Current Assets ratio of NEULAND LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹773 Cr |
| Mar2025 | ₹674 Cr |
| Mar2024 | ₹493 Cr |
| Mar2023 | ₹322 Cr |
| Mar2022 | ₹218 Cr |
How is Net Current Assets of NEULAND LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹773 Cr | 14.71 | |
| Mar2025 | ₹674 Cr | 36.57 | |
| Mar2024 | ₹493 Cr | 53.26 | |
| Mar2023 | ₹322 Cr | 47.92 | |
| Mar2022 | ₹218 Cr | - | |
Compare Net Current Assets of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹29,849.3 Cr | 3.6% | 23.1% | 78.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 3.6% |
23.1% |
78.1% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses